Detalles de la búsqueda
1.
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.
Transfusion
; 62(7): 1365-1376, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35748490
2.
Pathogen inactivation treatment of triple-dose apheresis platelets with amotosalen and ultraviolet a light.
Transfus Med
; 32(6): 505-511, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36124649
3.
Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia.
Br J Haematol
; 186(4): 625-636, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31148155
4.
Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.
Transfusion
; 59(11): 3350-3361, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31574181
5.
Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.
Transfus Apher Sci
; 58(6): 102665, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31740165
6.
Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
Transfusion
; 58(6): 1506-1515, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29607502
7.
Determination of acute lung injury after repeated platelet transfusions.
Blood
; 117(3): 1014-20, 2011 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20935256
8.
An unbalanced study that lacks power: a caution about IPTAS.
Transfusion
; 57(9): 2284, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28868740
9.
Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.
Transfusion
; 49(7): 1412-22, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19389022
10.
Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
Transfusion
; 46(1): 24-33, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16398727
11.
Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study.
Transfusion
; 46(3): 424-33, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16533286
12.
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
Transfusion
; 46(10): 1693-704, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17002625
13.
Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
Transfusion
; 45(12): 1864-75, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16371039
14.
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.
Transfusion
; 45(11): 1739-49, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16271099
15.
Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.
Transfusion
; 45(9): 1443-52, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16131376
16.
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.
Blood
; 104(5): 1534-41, 2004 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15138160
Resultados
1 -
16
de 16
1
Próxima >
>>